The insulin in dosage market size value in Australia has experienced significant fluctuations over the past decade. From 2012 to 2022, the market's value showed variations, with notable peaks in 2013 and declines such as the sharp drops in 2016 and 2022. The year-on-year variations indicate periods of growth, such as a 19.42% increase in 2013 and periods of decline, such as a 9.75% decrease in 2022. The CAGR over the past five years transitioned from a positive 0.37% in 2016 to a slightly negative -1.9% by 2022, highlighting the market's volatility and the need for close monitoring of current trends.
Future trends to watch for:
- Advancements in insulin formulation and delivery methods
- Policy changes in healthcare and pharmaceutical regulations
- Impact of emerging technologies in diabetes management
- Response to potential market disruptions such as global health crises
How does Australia rank in Insulin in Dosage Market Size Value?
| # | 24 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 5,142,200,000 | 2023 | +4.22% | +3.16% | View data |
| 2 | 2 Germany | 2,490,600,000 | 2023 | -2.64% | -0.27% | View data |
| 3 | 3 United Kingdom | 1,864,000,000 | 2023 | +0.081% | +0.91% | View data |
| 4 | 4 Canada | 1,369,700,000 | 2023 | +1.89% | +2.55% | View data |
| 5 | 5 Japan | 1,340,600,000 | 2023 | -14.34% | -8.01% | View data |
| 6 | 6 Italy | 1,149,100,000 | 2023 | -2.49% | -2.35% | View data |
| 7 | 7 Spain | 810,390,000 | 2023 | -1.52% | -0.44% | View data |
| 8 | 8 Australia | 559,200,000 | 2023 | -0.72% | -0.31% | |
| 9 | 9 Netherlands | 431,700,000 | 2023 | +3.4% | -0.08% | View data |
| 10 | 10 Czech Republic | 331,020,000 | 2023 | +1.22% | +0.83% | View data |
Latest reports
US Diabetes Market Report- Q1 2025
The US Diabetes Market in Q1 2025 is characterized by a dynamic interplay of increasing diabetes prevalence, technological advancements, and regulatory shifts. With...
China Diabetes Market Report- Q1 2025
In the first quarter of 2025, the diabetes market in China continued its dynamic expansion, influenced by significant trends in digital diabetes management,...
Japan Diabetes Market Report- Q1 2025
The Japan diabetes market in the first quarter of 2025 is experiencing dynamic changes driven by technological advancements, regulatory shifts, and strategic corporate...
Germany Diabetes Market Report- Q1 2025
The Germany Diabetes Market in the first quarter of 2025 is marked by transformative trends and strategic developments in diabetes management and treatment....
India Diabetes Market Report- Q1 2025
The diabetes market in India continues to experience significant growth in Q1 2025, driven by the rising prevalence of Type 2 diabetes. This...
UK Diabetes Market Report- Q1 2025
The diabetes market in the UK is experiencing substantial growth in Q1 2025, driven by technological advancements, increased prevalence of diabetes, and evolving...
France Diabetes Market Report- Q1 2025
In the first quarter of 2025, the diabetes market in France demonstrated significant advancements and strategic shifts, driven by key industry players and...
Canada Diabetes Market Report- Q1 2025
The Canada diabetes market in Q1 2025 is characterized by significant advancements and strategic developments across various segments. The landscape is being reshaped...
Brazil Diabetes Market Report- Q1 2025
The first quarter of 2025 has witnessed significant developments in the Diabetes market in Brazil, marked by rising prevalence and transformative shifts in...
Italy Diabetes Market Report- Q1 2025
The Italian diabetes market in the first quarter of 2025 continues to show significant growth and innovation, driven by the rising prevalence of...
